Summary: Insulin-like growth factors are growth-promoting peptides structurally related to insulin which possess autocrine and paracrine activities. IGF-I is mainly synthesized in hepatocytes, but little is known about its paracrine action on hepatocyte-adjacent perisinusoidal hepatic stellate cells, the principal matrix producing precursor cell type in the liver. IGF-I might stimulate proliferation and phenotypical transformation of hepatic stellate cells into myofibroblasts, the cell type responsible for the excessive production of connective tissue elements during fibrogenesis. In this study we investigated the expression and function of the IGF-I receptor during transformation of isolated and cultured hepatic stellate cells. The respective stages of transformation of hepatic stellate cells were defined by determination of cellular smooth muscle iso-a-actin and retinyl-palmitate content, respectively. IGF-I receptor protein decreased stage-dependently down to 0.5 at the 4th day and about 0.17 at the 8th day. The number of IGF-I receptors was determined to be initially 1.3 X 10 5 /cell. Their quantity decreased to 0.8 Χ 10 5 sites/cell (4th day) down to 0.5 Χ 10 5 sites/cell at the 7th day and remained constant thereafter at 0.7 X 10 s sites/cell. Dissociation constants (K D ) for IGF-I range from 0.32-0.57 nmol/1 showing constantly high receptor affinity. Northern blot analyses revealed distinct upregulation of IGF-I receptor mRNA level during culture. It is concluded that hepatocyte-generated IGF-I and/or IGF-I binding proteins are candidate mediators of hepatic stellate cell activation during the initial period of transformation to myofibroblasts. After completion of transformation the cell becomes relatively refractory to the action of IGF-I as judged from receptor density.
Introduction
The perisinusoidal hepatic stellate cell (HSC, also termined vitamin A storing cell, fat storing cell, or Ito cell) (1, 2) has attracted much interest because of its prominent pathophysiological role as the precursor cell type responsible for liver fibrpgenesis (3) (4) (5) . Adjacent to endothelial cells and closely connected to hepatocytes by microvilli contact (6) , inflammatory stimuli activate the resting retinoid storing hepatic stellate cell to proliferate, to transform phenotypically into myofibroblasts (MFB), and to express and synthesize a wide variety of extracellular matrix components which accumulate during the development of fibrosis (7) (8) (9) (10) . Activation of hepatic stellate cells is generally regarded as the crucial step in the molecular and cellular pathogenesis of fibrogenesis (11, 12) .
The in situ transformation of hepatic stellate cells via transitional cells into myofibroblasts (13, 14) is characterized by ultrastructural changes and loss of specific cell contents (2) . The concentration of retinyl-palmitate is reduced and the expression of smooth muscle iso-aactin is strongly upregulated (15) (16) (17) . Similar to in situ activation of hepatic stellate cells in areas of necro-inflammation, a spontaneous transformation process is observed in isolated hepatic stellate cells grown on plain plastic support (18, 19) .
The growth promoting, insulin related peptide, insulinlike growth factor (IGF)-I is a candidate paracrine mediator of stimulation of hepatic stellate cell proliferation and transformation (20) . IGF-I 2 ) is produced in significant quantities by hepatocytes (21) (22) (23) (24) (25) (26) and is functionally modulated by co-synthesized IGF binding proteins (27) (28) (29) ; thus, the hepatic stellate cell is constantly exposed to a relatively high concentration of IGF-I in the immediate microenvironment. It was suspected that the action of IGF-I on hepatic stellate cells might depend strongly on the quantity and quality of the IGF-I receptor, a tyrosine kinase receptor related to the insulin receptor (30, 31) . In the present study, we established quantitative and qualitative measures of IGF-I receptor sites as a function of the respective stage of hepatic stell ) The financial support by grant Gr. 463/9-1 from the Deutsche Forschungsgemeinschaft is particularly acknowledged. 2 ) Abbreviation: IGF-I insulin-like growth factor-I late cell transformation to get a more detailed insight into the functional mechanism by which IGF might mediate hepatic stellate cell activation. It was found that receptor affinity and quantity are differently regulated during hepatic stellate cell transformation, which offers an additional regulation of hepatic stellate cell activation at the level of IGF-I receptor expression.
Materials and Methods

Chemicals and reagents
Enzymes for hepatic stellate cell isolation, Dulbecco's modified Eagle medium (DMEM), fetal calf serum (PCS), smooth muscle iso-a-actin antibodies, and human recombinant insulin-like growth factors-1/Il (hIGF-I/hlGF-11) were purchased from Boehringer Mannheim GmbH, Mannheim, Germany. Anti-hIGF-I rabbit antiserum (UB3-189) was a gift from Drs. Lows Underwood and Judson J. van I25 I]iodotyrosyl insulin-like growth factor-I (specific activity 74 TBq/mmol) and the enhanced chemoluminescence Western blotting detection kit were obtained from Amersham Buchler, Braunschweig, Germany. X-OMAT AR autoradiography film was from Kodak.
Isolation and culture of hepatic stellate cells
The isolation and characterization of hepatic stellate cells was performed as described previously (32, 33) . The purity of hepatic stellate cells was > 0.98 after the first medium change. The plating efficiency reached 0.52-0.61, and the viability of cells, assessed by trypan blue exclusion, was found to be > 0.95 after 24 h and after 6 d of culture, respectively. For receptor binding studies, hepatic stellate cells were seeded with a density of 1. ) and grown as monolayers in DMEM containing 0.1 fetal calf serum. Special care was taken to exclude nonspecific radioligand binding effects to culture well plastic surfaces and/or surface adherent IGF binding proteins derived from fetal calf serum supplement (34) , by presaturating with excess RIA grade bovine serum albumin (0.01, 3 h, 37 °C) before use. Medium changes were carried out at the 1 st, 4th and 8th day after seeding.
Determination of cell proliferation
The actual cell number at each stage of hepatic stellate cell transformation was indirectly determined by fluorometric measurement of the DNA content of two culture wells (4 cm 2 ) in triplicate, using calf thymus DNA as a standard (35) . DNA quantities were then correlated to phase contrast microscopic cell numerations. buffered saline and then reacted with fluorescein isothiocyanate-conjugated anti-mouse IgG (1 : 50 in phosphate buffered saline, 0.01 bovine serum albumin, 1 h, 22 °C). After two final washes with distilled water, the cell layers of four culture wells (8 cm 2 , triple determination) were scraped off, suspended in distilled water and pooled. Subsequent fluorometric measurement was carried out in an SFM-25 spectrofluorometer (Kontron Analytical, Eching, Germany) at an excitation wavelength of 470 nm, analysed at 520 nm emission wavelength. Immunofluorescence intensity was expressed as the complementary percentage value of the photomultiplier high voltage requirement to produce maximum sample fluorescence, compared to the absolute maximum value detected at the llth culture day. To confirm complete transformation of hepatic stellate cells, another reference value was taken at the 14th culture day.
Determination of cellular retinyl-palmitate content
All preparations were performed under light protected conditions. For triplicate determination, cell layers of two culture wells (4 cm 2 ) were washed twice with phosphate buffered saline, scraped off in 0.5 ml phosphate buffered saline suspension volume, and stored at -30 °C until use. Retinoids were extracted with /z-hexane after complete cell disruption by repeated freezing and thawing and protein precipitation with 0.5 (by vol.) ethanol. After phase separation (centrifugation at 600 g, 5 min, 4 °C), aliquots of the /z-hexane phase were taken for HPLC analysis (RP-18 column Nucleosil 100-5-Si, Latek, Heidelberg, Germany; mobile phase n-hexane iso-propanol, 94 + 6 (by vol.); flow rate 1.5 ml/min; UV-detection at 330 nm; 22 °C). The retinyl-palmitate concentration was calculated using the "External Standard Quantification" method of peak area integration of the recording integrator (Waters, Eschborn, Germany).
Isolation of total RNA and Northern blot hybridization analysis of IGF-I receptor mRNA
Total cellular RNA was extracted from freshly isolated, eight day old cultured hepatic stellate cells according to Chomczynski & Saachi (36) . For Northern blot analysis, total RNA was separated using a denaturating 0.012 agarose, 0.06 formaldehyde gel followed by the blotting procedure described elsewhere (37).
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot analysis
Cultures of differently transformed hepatic stellate cells (days 2, 4, 8) were extracted on ice, using 0.02 sodium dodecyl sulphate electrophoresis sample buffer in the presence of protease inhibitors. Aliquots (5 g/1 protein) were subjected to sodium dodecyl sulphate-PAGE (0.08 polyacrylamide) under non-reducing conditions using the discontinuous buffer system of Laemmli (38) . Prestained molecular weight markers were used. For immunoblotting, the electrophoresed samples were transformed onto nitrocellulose by fast semi-dry electroblotting (200 mA/8-20V, 30-45 min) using a synthetic carbon electrode blotting device (HLI, Landsberg, Germany) and incubated with specific primary antibodies against IGF-I receptor (final dilution 1 : 500). Bound antibodies were detected using the Amersham enhanced chemoluminescence Western detection kit.
Estimation of expression of cellular smooth muscle iso-a-actin by indirect immunofluorescence
Cell layers were washed twice with ice-cold phosphate buffered saline (PBS), pH 7.4, then fixed using 0.05 (by vol.) acetic acid in ethanol. Three washing steps with phosphate buffered saline was followed by blocking of unspecific binding with 1 : 2 diluted fetal calf serum (30 min, 22 °C). Cells were then reacted with smooth muscle anti-iso-aactin (1 :50) antibody in phosphate buffered saline containing 0.01 bovine serum albumin for 1 hour at ambient temperature on a rotating platform. I25 I]IGF-I displacement were carried out in plain culture dishes not presaturated or presaturated for 3 h at 37 °C with 10 g/l RIA grade bovine serum albumin both in the absence and presence of 0.1 (by vol.) fetal calf serum and/or 5 ng/well IGF-I.
Incubations were performed for 3 hours at 20 °C on a rotating platform and terminated by aspirating the supernatant, followed by immediate washings with ice cold binding buffer. Specifically bound radioactivity was then liberated from cell surfaces with 0.01 Triton X-100 in phosphate buffered saline for 15 minutes on a rotating platform (~ 180 min"" 1 , 22 °C). Radioactivity was measured in a Berthold gamma-counter (EG & G Berthold GmbH, Bad Wildbad, Germany). 
Results
Culture of rat liver hepatic stellate cells seeded with low density leads to continuous cell proliferation and completely transformed myofibroblasts ( fig. la-c) . The initially homogenously spread hepatic stellate cells started to change their spherical cell shape with perinuclear lipid droplets at the 3rd day after seeding by flattening and irregular increase in diameter, indicating the beginning of the transformation process ( fig. la) . During the following days, the cells developed characteristic cellular extensions along with actin fibers. In parallel, the number and size of fat droplets decreased ( fig. Ib) . Between the 7th and 9th culture days, hepatic stellate cells reached subconfluency and nearly all of them had a completely transformed myofibroblastic phenotype with no fat droplets visible ( fig. Ic) .
These morphological changes were accompanied by two measurable modifications used frequently as indicators of hepatic stellate cell transformation. Expression of smooth muscle iso-a-actin was monitored using the newly described fluorescein isothiocyanate-immunofluorescence assay, and cellular retinyl-palmitate content was determined by reverse phase HPLC ( fig. 2) . It could be shown that the different stages of cell transformation exhibit an antiparallel course of increasing actin expres- 2nd culture day down to about 0.5 at the 4th day and finally reached about 0.17 at the 8th day ( fig. 3 ).
To determine the specificity of IGF-I binding sites on rat hepatic stellate cells and to exclude non-specific IGF binding to plastic surfaces or to attached IGF binding proteins derived from fetal calf serum, exhaustive control experiments were carried out. As shown in figure 4 , presaturation of plastic culture wells with bovine serum albumin generally resulted in a reduction of non-specific binding of the radiolabelled peptide hormone. In general, presaturation with bovine serum albumin decreased cell, 0.08 amol/cell) and then stable numbers of 0.7 Χ 10 5 sites/cell (0.11 amol/cell) at the 9th and llth day were measured (tab. 1). Though detectable amounts of the IGF-I receptor were found to be present in myofibroblasts, IGF-I receptor activity seems to be predominantly present in the early phase of hepatic stellate cell transformation. In Northern blotting experiments, the steady state level of IGF-I receptor mRNA was very low in freshly isolated hepatic stellate cells (visible only after long exposure), but increased strongly in cells after 8 days in culture ( fig. 8 ).
Discussion
Close anatomical connection of hepatic stellate cells with hepatocytes (6, 40) , in combination with hepatic stellate cells stimulating activity present in hepatocyteconditioned media (41) , strongly suggests participation of parenchymal liver cells in hepatic stellate cell activation in necro-inflammatory areas of the liver (12, 42) . Our recent investigations show that IGF-I, which originates from cultured hepatocytes (21-26, 43 ), might be a candidate mediator of hepatic stellate cell activation (20) . Additionally, its stimulatory potential can be enhanced by specific IGF binding proteins (27, 28) , secreted at least partially by hepatocytes (20) . It was shown that hepatic stellate cells produce IGF as well as IGF binding proteins (44, 45) , suggesting the potential of an additional, autocrine pathway in addition to hepatocyte-derived stimuli. Although IGF-I should be present in significant concentrations in the microenvironment of hepatic stellate cells, nothing is known about the cognate receptor of hepatic stellate cells, which is crucial for the action of this cytokine (30) . The present study was based on the hypothesis that the expression and function of IGF-I receptor might be subject to variation during hepatic stellate cell transformation as is the case for other cytokine receptors on hepatic stellate cells, e. g. for PDGF 3 )-receptors (46) . By regulation of the receptor level and affinity, IGF-I originating either from autocrine or paracrine loops might obtain stagedependent activity on hepatic stellate cells.
To obtain full transformation of primary cells within one batch of culture, low seeding densities were chosen. Cell proliferation kinetics assured that no cellular contact inhibition took place until cells reached subconfluency at the 9th to llth day. Transformational stages were well documented by determining retinyl palmitate content and smooth muscle iso-c^actin expression using a newly developed immunofluorescence semiquantification method. A strong rise of actin antibody related fluorescein isothiocyanate fluorescence was measured at the end of the culture period, combined with a decrease of cellular retinyl palmitate content to 5 μg/10 6 cells; freshly seeded hepatic stellate cells contained about 20-30 pg ( fig. 9 ).
Reliability of the radioreceptor assay using radioiodinated IGF (34) was achieved by presaturation of culture wells with RIA-grade bovine serum albumin. Non-specific binding of the radioactive ligand to charged plastic surfaces and/or adherent IGF binding proteins originating from fetal calf serum supplement (47) In conclusion, our findings prove stage-dependent reduction of IGF-I receptor quantity, but not of affinity, during spontaneous transformation of hepatic stellate cells in culture as it is summarized in figure 9 . Since this phenotypic change mimics hepatic stellate cell transformation in injured liver, it is suggested that at least early stages of transforming hepatic stellate cells in rat liver might receive paracrine stimuli via hepatocytederived IGF-I, the activity of which can be modulated by specific IGF binding proteins. In addition, the paracrine IGF stimulation might be supplemented by an autocrine amplification mechanism by which hepatic stellate cells produce their own set of IGFs and IGF binding proteins and, as shown here, specifically regulate affinities and quantities of the respective receptor species. It is proposed that the highly sensitive IGF and/or IGF binding protein regulatory system might be involved in the mechanism of hepatic stellate cell activation at the onset of fibrogenesis. An intriguing observation made in this study concerns the question by which mechanism hepatic stellate cells are kept quiescent in normal liver although they are exposed continually to mitogenic IGF-I constitutively expressed and secreted by hepatocytes, and possess a significant quantity of high affinity IGF-I receptor, mainly in the untransformed status. As discussed previously, some antagonizing, inhibitory mechanisms keeping hepatic stellate cells in a resting condition have to be postulated (51) . Potential inhibitory mechanisms effective in the liver, which are of great interest both clinically and theoretically, might concern the extracellular matrix surrounding hepatic stellate cells, the presence of soluble inhibitors, and "hepatocyte contacting processes" between hepatic stellate cells and hepatocytes (40) . The latter structure might normally exert a kind of contact inhibition of hepatic stellate cells in situ, which is released during damage of hepatocytes, a prerequisite of the initiation of fibrogenesis in injured liver (11, 12) . Ongoing studies are concentrated on these topics.
